[1]
Kolesnyk, M.Y. and Mykhailovskyi, Y.M. 2022. Efficacy and safety of warfarin therapy in patients with atrial fibrillation using genotype-guided dosing method. Zaporozhye Medical Journal. 24, 4 (Sep. 2022), 390–395. DOI:https://doi.org/10.14739/2310-1210.2022.4.256945.